首页> 外文期刊>Biotechnology and Applied Biochemistry >Preparation and anti-tumor efficiency evaluation of bacterial magnetosome-anti-4-1BB antibody complex: Bacterial magnetosome as antibody carriers isolated from Magnetospirillum gryphiswaldense
【24h】

Preparation and anti-tumor efficiency evaluation of bacterial magnetosome-anti-4-1BB antibody complex: Bacterial magnetosome as antibody carriers isolated from Magnetospirillum gryphiswaldense

机译:细菌磁体 - 抗4-1BB抗体复合物的制备和抗肿瘤效率评价:从磁摩托列马省Gryphiswaldense分离的抗体载体的细菌磁体

获取原文
获取原文并翻译 | 示例
           

摘要

Bacterial magnetosomes (BMs) are used as carriers for antibodies, enzymes, and nucleic acids. This study aimed to demonstrate the clinical utility of BMs derived from Magnetospirillum gryphiswaldense for use in anti-tumor immunotherapy. Bis(sulfosuccinimidyl) suberate (BS3) was used to prepare BM-anti-4-1BB antibody complexes. We used syngeneic TC-1 mouse models of cancer to investigate whether BMs combined with an anti-4-1BB agonistic antibodies could enhance the therapeutic effects of anti-4-1BB antibodies in localized disease settings. Anti-4-1BB antibodies were combined with purified BMs at a concentration of 168 mg antibody per milligram BM (mg IgG/mg BM) using BS3. The anti-4-1BB antibody-coupled BMs (BM-Ab complexes) and control BMs displayed similar morphologies and measurements when examined by transmission electron microscope (TEM). In a mouse tumor model, intravenous injection of BM-Abs combined with magnetic treatment resulted in greater tumor protection than did other treatment methods (P < 0.05). These results demonstrate the in vivo anti-tumor properties of BM-Abs complexes. The coupling of anti-4-1BB antibodies to magnetosomes may have potential for clinical application to antitumor antibody therapy.
机译:细菌磁或BMS)用作抗体,酶和核酸的载体。本研究旨在证明源自磁摩托列姆Gryphiswaldense用于抗肿瘤免疫疗法的BMS的临床效用。使用BIS(磺琥珀酰亚胺酰亚胺基)由Suberate(BS3)制备BM-抗4-1BB抗体复合物。我们使用的同系TC-1小鼠模型的癌症探讨了BMS是否与抗-4-1BB激动抗体结合可以增强抗-4-1BB抗体在局部疾病环境中的治疗效果。使用BS3将抗4-1BB抗体与浓度为168mg抗体(Mg IgG / Mg BM)的浓度为168mg抗体的纯化的BMS。当通过透射电子显微镜(TEM)检查时,抗4-1BB抗体偶联的BMS(BM-AB复合物)和对照BMS显示相似的形态和测量。在小鼠肿瘤模型中,静脉注射BM-ABS与磁性处理相结合导致肿瘤保护较大,而不是其他治疗方法(P <0.05)。这些结果证明了BM-ABS配合物的体内抗肿瘤性质。抗4-1BB抗体对磁或磁性体的偶联可能具有临床应用于抗肿瘤抗体治疗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号